Innovative Psychedelics Expands Access to IV Ketamine Therapy for Chronic Pain and Mood Disorders

Innovative Psychedelics, a clinic at the forefront of mental health treatments, has announced the availability of new patient appointments for IV ketamine therapy. This treatment is aimed at individuals battling severe depression, mood disorders, and chronic pain, offering hope to those who have found little relief from traditional therapies. The clinic's team of medical professionals utilizes the latest technology to deliver personalized care, ensuring each patient's treatment plan is tailored to their specific needs.

Among the conditions treated by Innovative Psychedelics are cancer, CRPS, fibromyalgia, neuropathic pain, phantom pain, postherpetic neuralgia, sickle cell disease, and spinal injuries. The clinic's approach to pain management includes a three-hour infusion of ketamine, typically administered once a month. It is crucial for patients to understand that while ketamine infusion has shown promise in treating mood and pain disorders, its use for these purposes is off-label and not approved by the FDA. Potential side effects include high blood pressure, nausea, vomiting, and perceptual disturbances.

Innovative Psychedelics has also gained recognition for its successful implementation of Spravato treatments, further solidifying its reputation as a leader in innovative mental health solutions. With locations in Chicago and Downers Grove, IL, the clinic is expanding access to these cutting-edge treatments, providing a beacon of hope for many. For more information on their services, including contact details and hours of operation, interested parties are encouraged to visit the clinic's website.